Cerus (CERS) Operating Margin Growth (1y) (2011 - 2026)
Cerus (CERS) Operating Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.62 Bn | 197.02 Bn | 7.27 Bn | -497.00 |
| 2 | Stryker | 126.48 Bn | 123.00 Bn | 4.50 Bn | 670.00 |
| 3 | Medtronic | 119.39 Bn | 110.17 Bn | 6.41 Bn | 301.00 |
| 4 | Boston Scientific | 74.22 Bn | 73.68 Bn | 3.85 Bn | 546.00 |
| 5 | Edwards Lifesciences | 51.61 Bn | 47.35 Bn | 1.35 Bn | 264.00 |
| 6 | Dexcom | 34.96 Bn | 33.02 Bn | 830.00 Mn | 595.00 |
| 7 | GE HealthCare Technologies | 33.73 Bn | 31.62 Bn | 2.18 Bn | 89.00 |
| 8 | Koninklijke Philips | 26.21 Bn | 22.89 Bn | 4.55 Bn | -247.00 |
| 9 | Steris | 23.17 Bn | 22.69 Bn | 684.20 Mn | 146.00 |
| 10 | Cerus | 564.59 Mn | 508.33 Mn | 29.53 Mn | 329.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 329.00 |
| Mar 31, 2026 | 1,288.00 |
| Dec 31, 2025 | 153.00 |
| Sep 30, 2025 | 15,447.00 |
| Jun 30, 2025 | -61,303.00 |
| Mar 31, 2025 | 726.00 |
| Dec 31, 2024 | -254.00 |
| Sep 30, 2024 | 285,793.00 |
| Jun 30, 2024 | 1,721.00 |
| Mar 31, 2024 | 8,004.00 |
| Dec 31, 2023 | 585.00 |
| Sep 30, 2023 | -288,603.00 |
| Jun 30, 2023 | -1,329.00 |
| Mar 31, 2023 | -3,431.00 |
| Dec 31, 2022 | 77.00 |
| Sep 30, 2022 | 7,640.00 |
| Jun 30, 2022 | 8,165.00 |
| Mar 31, 2022 | 10,366.00 |
| Dec 31, 2021 | 928.00 |
| Sep 30, 2021 | 208,713.00 |